A smart ring that treats blood pressure like a vital sign, not a fitness metric
The Signal Ring is a new USD 399 (approx. RM1,850) smart ring from health tech startup Vital Signals that aims to deliver cuffless, calibration-free systolic and diastolic blood pressure readings directly from the finger, with continuous tracking designed for people living with hypertension and other cardiac conditions. That is a bold claim, and it marks a clear shift in what smart rings are supposed to be for. Instead of being another sleep-and-steps accessory, Signal Ring is positioned as a medical‑style tool you wear all day so dangerous spikes never slip past unnoticed. If it works as promised, smart ring blood pressure could move from fuzzy trends to clinical‑grade numbers—and that would change how we manage high blood pressure at home.
How Signal Ring’s cuffless blood pressure monitoring works—and why it matters
Vital Signals says Signal Ring uses optical sensors plus specialized algorithms to detect blood pressure fluctuations throughout the day, instead of the occasional arm‑cuff readings most people tolerate at the clinic. Unlike many wearables that estimate pressure but must be regularly calibrated with a physical cuff, this ring promises cuffless blood pressure monitoring with no calibration at setup. That algorithm‑first strategy is the real innovation: by removing the cuff entirely, the company is betting its software can stay accurate without the usual “re‑zeroing” that causes drift on other devices. According to company materials, the system was tested in a 451‑person clinical study and is claimed to meet “the international accuracy standard for blood pressure cuffs,” a bar traditional monitors are judged against. Until those results are public, this remains a promising, not proven, leap.
Continuous blood pressure tracking could reshape daily life with hypertension
The real power of cuffless tech is not a prettier reading—it is what happens when readings never stop. Signal Ring automatically collects data through the day and night, then displays continuous blood pressure tracking as graphs and overnight trends in its app. Users can also trigger on‑demand checks; the app prompts them to sit, relax, and slow their breathing while a more focused measurement is taken, and then lets them tag context such as workouts, meals, smoking, or coffee. For anyone among the 48.1% of adults with high blood pressure, continuous monitoring that fits on a finger would be far less disruptive than strapping on a cuff multiple times a day. This is exactly the kind of quiet, passive tracking that could help people and clinicians see dangerous patterns long before they turn into an ER visit.
From wellness toy to clinical tool: why this smart ring is different
Signal Ring arrives as a deliberate rebuke to the wellness‑first wearables crowd. Founder Tom Moss argues that most devices obsess over steps and sleep while missing the vital signals that actually send people to hospital, like hypertension. His own emergency with a systolic reading of 250 mmHg—and the lack of any device offering accurate continuous blood pressure monitoring he could wear all day—pushed him to start Vital Signals and spend three years building this ring with engineers from a pulse sensor company. Unlike current smart rings that only infer cardiovascular risk from trends, Signal Ring goes straight for clinical‑style blood pressure numbers and is being readied for regulatory clearance so it can one day work with insurers and become part of daily preventive care. Crucially, there is no subscription: once you buy the hardware, you get the continuous monitoring without ongoing fees.
Promise, skepticism, and what happens next
For all its promise, Signal Ring is not yet cleared as a medical device, and experts are right to be skeptical. The company has not fully detailed its sensing tech, but it likely relies on PPG light sensors, which can be affected by motion, darker skin tones, cold fingers, poor circulation, and irregular heartbeats—all of which can distort readings and undermine accuracy. That is why some cardiologists want to see more rigorous, peer‑reviewed testing before treating smart ring blood pressure as a cuff replacement. Pre‑orders are open now with shipping expected around October, and Vital Signals still plans to pursue formal regulatory clearance even as rules for optical blood pressure devices start to loosen. If the data holds up in the real world, this ring will not just be another gadget—it will mark the moment smart rings stepped into clinical‑grade health monitoring and changed how we live with hypertension.
